» Articles » PMID: 16840724

EphB2 and EphB4 Receptors Forward Signaling Promotes SDF-1-induced Endothelial Cell Chemotaxis and Branching Remodeling

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2006 Jul 15
PMID 16840724
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

The complex molecular mechanisms that drive endothelial cell movement and the formation of new vessels are poorly understood and require further investigation. Eph receptor tyrosine kinases and their membrane-anchored ephrin ligands regulate cell movements mostly by cell-cell contact, whereas the G-protein-coupled receptor CXCR4 and its unique SDF-1 chemokine ligand regulate cell movement mostly through soluble gradients. By using biochemical and functional approaches, we investigated how ephrinB and SDF-1 orchestrate endothelial cell movement and morphogenesis into capillary-like structures. We describe how endogenous EphB2 and EphB4 signaling are required for the formation of extracellular matrix-dependent capillary-like structures in primary human endothelial cells. We further demonstrate that EphB2 and EphB4 activation enhance SDF-1-induced signaling and chemotaxis that are also required for extracellular matrix-dependent endothelial cell clustering. These results support a model in which SDF-1 gradients first promote endothelial cell clustering and then EphB2 and EphB4 critically contribute to subsequent cell movement and alignment into cord-like structures. This study reveals a requirement for endogenous Eph signaling in endothelial cell morphogenic processes, uncovers a novel link between EphB forward signaling and SDF-1-induced signaling, and demonstrates a mechanism for cooperative regulation of endothelial cell movement.

Citing Articles

Recent advances of the Ephrin and Eph family in cardiovascular development and pathologies.

Zhu Y, Su S, Shen J, Ma H, Le J, Xie Y iScience. 2024; 27(8):110556.

PMID: 39188984 PMC: 11345580. DOI: 10.1016/j.isci.2024.110556.


Inhibition of Ephrin B2 Reverse Signaling Abolishes Multiple Myeloma Pathogenesis.

Sasine J, Kozlova N, Valicente L, Dukov J, Tran D, Himburg H Cancer Res. 2024; 84(6):919-934.

PMID: 38231476 PMC: 10940855. DOI: 10.1158/0008-5472.CAN-23-1950.


An investigation of binding interactions of tumor-targeted peptide conjugated polyphenols with the kinase domain of ephrin B4 and B2 receptors.

Mitchell S, Heise R, Murray M, Lambo D, Daso R, Banerjee I Mol Divers. 2023; 28(2):817-849.

PMID: 36847923 PMC: 9969393. DOI: 10.1007/s11030-023-10621-x.


The Roles of EphB2 in Cancer.

Liu W, Yu C, Li J, Fang J Front Cell Dev Biol. 2022; 10:788587.

PMID: 35223830 PMC: 8866850. DOI: 10.3389/fcell.2022.788587.


Glomerular Endothelial Cells Are the Coordinator in the Development of Diabetic Nephropathy.

Li T, Shen K, Li J, Leung S, Zhu T, Shi Y Front Med (Lausanne). 2021; 8:655639.

PMID: 34222276 PMC: 8249723. DOI: 10.3389/fmed.2021.655639.


References
1.
Kullander K, Klein R . Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol. 2002; 3(7):475-86. DOI: 10.1038/nrm856. View

2.
Salcedo R, Wasserman K, Young H, Grimm M, Howard O, Anver M . Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol. 1999; 154(4):1125-35. PMC: 1866563. DOI: 10.1016/s0002-9440(10)65365-5. View

3.
Steinle J, Meininger C, Forough R, Wu G, Wu M, Granger H . Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J Biol Chem. 2002; 277(46):43830-5. DOI: 10.1074/jbc.M207221200. View

4.
Endo A, Ogita H, Kawana A, Yamagishi A, Kitabatake A, Matsuda M . Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells. Mol Biol Cell. 2002; 13(12):4231-42. PMC: 138629. DOI: 10.1091/mbc.e02-04-0181. View

5.
Zhou Y, Larsen P, Hao C, Yong V . CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem. 2002; 277(51):49481-7. DOI: 10.1074/jbc.M206222200. View